Israel's coronavirus infection rate stands at 2.7%, according to Health Ministry data, as 3,186 of the 126,497 people who tested for the virus Monday were found to have COVID-19.
Follow Israel Hayom on Facebook and Twitter
The reproduction rate continues to decline and now stands at 0.74.
There are 37,553 active cases. There are 505 people who are seriously ill, 198 of whom are on ventilators.
Although 1,249,149 Israelis have recovered from the coronavirus since the outbreak of the pandemic, 7,843 have died.
On the vaccination front, 6,150,462 Israelis have received at least one dose of the coronavirus vaccine, while 5,661,428 have received two doses. According to the Health Ministry, at least 3,594,416 have received all three available doses of the vaccine.
A Health Ministry research study has revealed that while around 30% of all those who recovered from the virus in Israel suffer from long COVID in the first six months following their recovery, 11.2% of children suffered from at least one symptom of long COVID.
Between 1.8% and 4.6% of children continued to suffer from long COVID over six months after recovering from the virus.
The Health Ministry's findings are in line with that of other research studies performed around the world, according to which one in seven children will experience at least one symptom of long COVID in the first six months of recovery.
However, a new UK study found that, unlike adults, just 2% of children experience long COVID.
Ronit Calderon-Margalit of the Hebrew University of Jerusalem's School of Medicine explained: "What the [UK] researchers did was examine how many children have symptoms of long COVID after recovering from the disease compared to children who never fell ill The findings demonstrated something interesting: When you only ask children who recovered from the virus, you get to a significant rate of around 14% who have symptoms of long COVID, with an emphasis on one symptom. But after presenting the same question to children who weren't infected, they discovered that they too experienced one coronavirus symptom.
"In effect, out of 50,000 children who had not contracted the virus, 53% had one symptom, and among children who contracted the virus, the rate stood at 65%." She said 16% of those who had not contracted the virus experienced two symptoms compared to 30% of those who had recovered from COVID-19.
According to Calderon-Margalit, the study made clear that some of the symptoms were "not necessarily related to the virus itself but were related to the general atmosphere, to the lockdowns, the quarantines. So, in reality, the number of children who suffered and experienced long COVID was very low.
"That's good news," she said. "I'm happy to discover that in contrast with initial concerns," children do not experience long COVID to the same extent as adults, "where the damage is more severe." She noted experts had yet to conclude whether the coronavirus vaccine prevented symptoms of long COVID."
Dr. Liat Ashkenazi-Hoffnung, the director of Day Care Hospitalizations at the Schneider Children's Medical Center, said that "as far as the prevalence of the coronavirus, we have two significant studies from England and the Health Ministry in Israel, and three studies that were carried out with more or less the same method. What we can learn from them is that 4% of children will develop long COVID symptoms that need to be treated."
She explained: "There are a few central symptoms, which are chest pain, sleep apnea, fatigue, shortness of breath, headaches that cannot be treated with regular pain medicine. Likewise, there is dizziness, muscle pain, joint pain, hair loss. We also seep symptoms related to the individual's digestive system, as in vomiting, diarrhea, loss of appetite, the loss of the sense of taste and smell, or smelling burned food. In some instances, children become extremely picky with food, and therefore barely eat anything, and there is even extreme weight loss of 20 kg," she said.
Asked why people experience long COVID, she noted several explanations, including infection, but said her hospital had seen no evidence of this in children.
"The more logical explanation is that there is damage to the autonomic nervous system associated with the heart, the lungs, and various systems spread out across the body, and that is also why there are so many side effects," she said.
"It is also important to note that I'm not talking about seriously ill patients who are hospitalized, who experienced noticeable damage to their organs. I'm talking about people who were moderately ill or who weren't ill at all and experienced these symptoms. That is why the question is what happened, and we assume that it's a type of damage to this peripheral nervous system."
Meanwhile, the European Union's drug regulator gave its backing Monday to administering booster shots of the Pfizer-BioNTech COVID-19 vaccine for people aged 18 and older.
The European Medicines Agency said the booster doses "may be considered at least 6 months after the second dose for people aged 18 years and older."
The agency's human medicines committee issued the recommendation after studying data for the Pfizer vaccine that showed a rise in antibody levels following boosters given around 6 months after the second dose in people aged 18 to 55.
The agency also said it supports giving a third dose of either the Pfizer-BioNTech or the Moderna vaccine to people with severely weakened immune systems at least 28 days after their second shot.
The agency said its decision came after studies showed that an extra dose of the vaccines increased people's ability to produce antibodies against the virus that causes COVID-19 in organ transplant patients with weakened immune systems.
"Although there is no direct evidence that the ability to produce antibodies in these patients protected against COVID-19, it is expected that the extra dose would increase protection at least in some patients," the agency said in a statement.
The EMA recommendations go to the European Commission for approval and then to health authorities in all 27 EU nations, whose national health authorities decide on vaccination strategies. Some countries already have begun administering booster shots.
Numerous studies have shown that the Pfizer-BioNTech and Moderna vaccines remain strongly protective months after people receive their second dose, dramatically cutting the risk of hospitalization and death.
The World Health Organization's chief had urged wealthy nations not to use booster doses this year, saying there is no scientific data that proves the shots are necessary. He said COVID-19 vaccines would be put to better use in developing countries, where many people still have not received their first vaccine shots.
The United States government launched a campaign last month to offer boosters of Pfizer's COVID-19 vaccine to millions of Americans even as federal health officials stressed the real problem remains to get first shots to the unvaccinated.
Pfizer-BioNTech said in a statement that they "do not expect the introduction of booster doses in the United States and the EU, if authorized, to impact the existing supply agreements in place with governments and international health organizations around the world."
The coronavirus pandemic has killed at least 4.8 million people around the world.
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
